Affordable Insulin for All Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Feb 4, 2020)
Affordable Insulin for All Act
This bill addresses insulin affordability.
For example, the bill requires the Department of Health and Human Services (HHS) to enter into agreements with insulin manufacturers to enable individuals with diagnosed diabetes to access Medicaid prices for insulin drugs.
Additionally, Medicare and private insurance plans must cap cost-sharing at $10 per month for insulin drugs, and HHS must revise regulations to exclude payments made for insulin drugs from the denominator of the medical loss ratio.
The bill also (1) eliminates a safe harbor for certain rebates, discounts, or price concessions for insulin drugs paid by a drug manufacturer to a pharmacy benefit manager for purposes of federal health care fraud and abuse laws; and (2) prohibits certain drug pricing activities related to supplemental rebates and spread pricing in Medicaid.
The Government Accountability Office must report on the feasibility and affordability of direct manufacturing by the federal government.
What just happenedFeb 4, 2020
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseFeb 4, 2020
- Feb 4, 2020Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Feb 4, 2020IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Feb 4, 2020IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Feb 4, 2020IntroReferralIntro-H
Introduced in House
- Feb 4, 2020IntroReferral1000
Introduced in House